← Back

Improved & New Gene Therapy Delivery Vehicles

Develop improved gene therapy vectors that can be manufactured at scale, as well as completely novel therapeutic gene therapy delivery vehicles. 

Resources (3)

R&D Gaps (1)

Current in-vivo delivery systems (viral vectors, nanoparticles, microchips) face challenges such as off-target accumulation and inefficiency, particularly in delivering therapies to the brain. Novel delivery approaches are needed to improve targeting and performance.